David Millan

3.0k total citations
41 papers, 996 citations indexed

About

David Millan is a scholar working on Epidemiology, Obstetrics and Gynecology and Reproductive Medicine. According to data from OpenAlex, David Millan has authored 41 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 15 papers in Obstetrics and Gynecology and 14 papers in Reproductive Medicine. Recurrent topics in David Millan's work include Cervical Cancer and HPV Research (14 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Ovarian cancer diagnosis and treatment (12 papers). David Millan is often cited by papers focused on Cervical Cancer and HPV Research (14 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Ovarian cancer diagnosis and treatment (12 papers). David Millan collaborates with scholars based in United Kingdom, United States and Australia. David Millan's co-authors include James Paul, Robert Brown, Jean Sargent, Gordon Strathdee, Kim Appleton, Sheila V. Graham, Kate Cuschieri, Nadeem Siddiqui, Gavin Stuart and Edgar Petru and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Radiology.

In The Last Decade

David Millan

41 papers receiving 975 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Millan United Kingdom 18 368 328 273 266 184 41 996
James Scurry Australia 19 358 1.0× 392 1.2× 261 1.0× 257 1.0× 257 1.4× 54 1.2k
Chih‐Ming Ho Taiwan 18 318 0.9× 284 0.9× 162 0.6× 260 1.0× 143 0.8× 31 829
M. Ruhul Quddus United States 19 176 0.5× 372 1.1× 468 1.7× 233 0.9× 170 0.9× 102 1.1k
Alexander Mustea Germany 14 197 0.5× 164 0.5× 293 1.1× 243 0.9× 198 1.1× 55 938
Jitze M. Duk Netherlands 13 139 0.4× 325 1.0× 388 1.4× 266 1.0× 194 1.1× 15 794
Michael L. Cibull United States 16 147 0.4× 241 0.7× 159 0.6× 116 0.4× 255 1.4× 34 1.0k
Sumalee Siriaunkgul Thailand 20 174 0.5× 469 1.4× 444 1.6× 591 2.2× 521 2.8× 80 1.3k
Daisy M. D. S. Sie‐Go Netherlands 19 97 0.3× 298 0.9× 396 1.5× 227 0.9× 257 1.4× 33 1.0k
Stuart C. Lauchlan United States 19 235 0.6× 667 2.0× 381 1.4× 186 0.7× 277 1.5× 36 1.2k

Countries citing papers authored by David Millan

Since Specialization
Citations

This map shows the geographic impact of David Millan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Millan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Millan more than expected).

Fields of papers citing papers by David Millan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Millan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Millan. The network helps show where David Millan may publish in the future.

Co-authorship network of co-authors of David Millan

This figure shows the co-authorship network connecting the top 25 collaborators of David Millan. A scholar is included among the top collaborators of David Millan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Millan. David Millan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Friedländer, Michael, Charlotte Benson, Rachel O’Connell, et al.. (2021). Phase 2 study of anastrozole in patients with estrogen receptor/progesterone receptor positive recurrent low-grade endometrial stromal sarcomas: The PARAGON trial (ANZGOG 0903). Gynecologic Oncology. 161(1). 160–165. 8 indexed citations
2.
Pan, Jiafeng, Kimberley Kavanagh, Kate Cuschieri, et al.. (2019). Increased risk of HPV‐associated genital cancers in men and women as a consequence of pre‐invasive disease. International Journal of Cancer. 145(2). 427–434. 16 indexed citations
3.
Bagnoli, Marina, Tingyan Shi, Charlie Gourley, et al.. (2019). Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions. Cells. 8(3). 200–200. 6 indexed citations
4.
Wakeham, Katie, Jiafeng Pan, Kevin G. Pollock, et al.. (2019). A Prospective Cohort Study of Human Papillomavirus-Driven Oropharyngeal Cancers: Implications for Prognosis and Immunisation. Clinical Oncology. 31(9). e132–e142. 7 indexed citations
5.
Cooke, Susanna L., Darren Ennis, Lisa Evers, et al.. (2017). The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma. Clinical Cancer Research. 23(24). 7633–7640. 29 indexed citations
6.
Duffy, S W, et al.. (2017). Malignant tumours arising within mature cystic teratomas of the ovary: Prevalence and clinical outcomes. European Journal of Obstetrics & Gynecology and Reproductive Biology. 221. 198–199. 3 indexed citations
7.
Léary, Alexandra, Michael Quinn, Keiichi Fujiwara, et al.. (2016). Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours. Annals of Oncology. 28(4). 718–726. 31 indexed citations
8.
Duffy, Siobhan, Gareth Bryson, S Shanbhag, et al.. (2016). Multifocal FIGO Stage IA1 Squamous Carcinoma of the Cervix: Criteria for Identification, Staging, and its Good Clinical Outcome. International Journal of Gynecological Pathology. 35(5). 467–474. 12 indexed citations
9.
Reed, Nick, et al.. (2015). Adequacy of cervical sampling in hysterectomy specimens for endometrial cancer. Annals of Diagnostic Pathology. 19(2). 43–44. 5 indexed citations
10.
Müller, Marietta, Christopher W. Wasson, Ramya Bhatia, et al.. (2015). YIP1 family member 4 (YIPF4) is a novel cellular binding partner of the papillomavirus E5 proteins. Scientific Reports. 5(1). 12523–12523. 15 indexed citations
11.
Hasegawa, Kosei, Shoji Nagao, Masanori Yasuda, et al.. (2014). Gynecologic Cancer InterGroup (GCIG) Consensus Review for Clear Cell Carcinoma of the Uterine Corpus and Cervix. International Journal of Gynecological Cancer. 24(9 Suppl 3). S90–S95. 44 indexed citations
12.
Glasspool, Rosalind, Antonio González-Martı́n, David Millan, et al.. (2014). Gynecologic Cancer InterGroup (GCIG) Consensus Review for Squamous Cell Carcinoma of the Ovary. International Journal of Gynecological Cancer. 24(9 Suppl 3). S26–S29. 16 indexed citations
13.
Dai, Wei, Jens M. Teodoridis, Constanze Zeller, et al.. (2011). Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival. Clinical Cancer Research. 17(12). 4052–4062. 78 indexed citations
14.
Cullis, Paul A., et al.. (2011). Vulval intraepithelial neoplasia: making sense of the literature. The Obstetrician & Gynaecologist. 13(2). 73–78. 2 indexed citations
15.
Gordon, D., et al.. (2011). Use of cetrorelix in the investigation of testosterone excess in a postmenopausal woman. BMJ Case Reports. 2011. bcr0120113730–bcr0120113730. 6 indexed citations
16.
Reed, Nicholas S., David Millan, René H.M. Verheijen, & M. Castiglione. (2010). Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. 21. v31–v36. 15 indexed citations
17.
Cuschieri, Kate, David Brewster, Alistair Williams, et al.. (2010). Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. British Journal of Cancer. 102(5). 930–932. 16 indexed citations
18.
Aitken, Emma, Aradhana Khaund, Shabaz A. Hamid, David Millan, & Steven C. Campbell. (2006). The normal human myometrium has a vascular spatial gradient absent in small fibroids. Human Reproduction. 21(10). 2669–2678. 20 indexed citations
19.
Jones, Robert H., Jean–Claude Reubi, David Millan, & P. Vasey. (2004). Octreotide: an active agent in epithelial ovarian carcinoma?. The Lancet Oncology. 5(4). 251–253. 7 indexed citations
20.
O’Brien, Philippa M., et al.. (2001). Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunology Immunotherapy. 50(10). 523–532. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026